Romark Report issue

Contributed to NME For profit Phase 2 Phase 3
Founded: Tampa FL United States (1896)

Organization Overview

First Clinical Trial
1999
NCT00002158
First Marketed Drug
2002
nitazoxanide (alinia)
First NDA Approval
2002
nitazoxanide (alinia)
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

ROMARK | Romark Laboratories L.C. | The Romark Institute for Medical Research